Intermetatarsal Bursitis in Patients With Rheumatoid Arthritis

• Status: Not yet recruiting
• Trial end date: 2024-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is to investigate the incidence and clinical implications of intermetatarsal bursitis (IMB) in patients with rheumatoid arthritis (RA).

The hypothesis is that IMB is a cause of pain in patients with RA.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rigshospitalet, Denmark
• Collaborator: The Danish Rheumatism Association

Criteria

Inclusion Criteria:

• Age > 18 years

• Forefoot pain and diagnosed with RA (patient group)

• Diagnosed with an axial arthritis (control group)

Exclusion Criteria:

• Age <18 years

• Open wounds or ongoing infection in the forefoot at the time of examination

• Persons with a history of significant trauma in the forefoot, e.g. any fracture or previous surgeries in the forefoot

• Persons who have previously received intermetatarsal treatment (Morton's neuroma or IMB) in the same foot, e.g. injection within 6 months or operation at any time

• Exclusion from MRI scan only:

• Persons with contraindications to participate in MRI scan

• Persons with severely impaired renal function (GFR <30 ml/min)